Justicidin B: A Promising Bioactive Lignan†
AbstractAdverse effects and drug resistance to the current onchopharmacologicals have increased the demand for alternative novel therapeutics. We herein introduce justicidin B, an arylnaphthalen lignan isolated from different plant origins, especially Justicia, Phyllanthus, Haplophyllum and Linum species. This cyclolignan exhibits a wide array of biological properties ranges from piscicidal to antifungal, antiviral and antibacterial activities. Activity against Trypanosoma brucei makes justicidin B a potential antiprotozoal agent for the treatment of neglected tropical diseases. Pharmacological properties like antiplatelet, anti-inflammatory and bone resorption inhibition have been also attributed to justicidin B. This compound is a potent cytotoxic substance on several cell lines, especially chronic myeloid and chronic lymphoid leukemia. Pharmacological values, natural variation, as well as biotechnological production of justicidin B by plant cell, tissue and organ culture are also described in this review. Chemical characteristics and chromatographic methods to identify justicidin B and its biosynthetic pathway have been discussed. Different approaches to the total synthesis of justicidin B are compared. This review would shed light on the role of justicidin B as an intriguing natural compound and provides a chance to optimize conditions for industrial applications. View Full-Text
Share & Cite This Article
Hemmati, S.; Seradj, H. Justicidin B: A Promising Bioactive Lignan. Molecules 2016, 21, 820.
Hemmati S, Seradj H. Justicidin B: A Promising Bioactive Lignan. Molecules. 2016; 21(7):820.Chicago/Turabian Style
Hemmati, Shiva; Seradj, Hassan. 2016. "Justicidin B: A Promising Bioactive Lignan." Molecules 21, no. 7: 820.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.